EUVIMEDEUVIMED entdecken
Crossref

Regulation of Human Colorectal Cancer Cells in Tumor Spheroids by Sodium Butyrate

Yuzuki Takahama, An Kadoi, Yuno Tauchi, Satsuki Kasahara, Kyota Ishii, Tomohiro Yano

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Yuzuki Takahama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Food and Nutritional Sciences, Toyo University, 48-1 Oka, Asaka, Saitama 351-8510, Japan. Hauptthemen laut MEDLINE: Spheroids, Cellular, Butyric Acid, Colorectal Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrate exerts strong anti-colorectal cancer effects via epigenetic regulation. However, whether butyrate has a negative impact on colorectal cancer in vivo remains unclear. Therefore, this study aimed to investigate whether butyric acid can regulate the growth of colorectal cancer cells using spheroids as an in vivo model. A three-dimensional (3D) culture system was used to form spheroids from the human colorectal cancer cell line HT-29. Spheroids formed in the 3D culture system exhibited some malignant cancer phenotypes (increased cancer stem cell marker levels, anticancer drug resistance, and G0/G1 phase accumulation in the cell cycle) compared with cells in the two-dimensional cell culture system. Sodium butyrate (SB) treatment suppressed cancer stem cell marker levels in spheroids and induced differentiation by increasing the alkaline phosphatase activity. Additionally, SB-induced changes in genes related to cell cycle control indicated that SB reactivated the cell cycle in spheroids, regulating the transition from the G0 to G1 phase. Furthermore, SB treatment induced cell death via apoptosis, which might be due to G1 arrest in the cell cycle. In conclusion, SB induced the differentiation and subsequent cell death of HT-29-derived cancer cells in spheroids, highlighting its potential as a novel anticancer agent for colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spheroids, CellularButyric AcidColorectal NeoplasmsAntineoplastic AgentsHumansHT29 CellsApoptosisCell CycleCell DifferentiationNeoplastic Stem Cells

Stichwörter der Autor:innen

HT-29 cellcell cycle reactivationcolorectal cancerdifferentiationsodium butyratespheroid

Substanzen

Butyric AcidAntineoplastic Agents

Autor:innen und Institutionen

  • Graduate School of Food and Nutritional Sciences, Toyo University, 48-1 Oka, Asaka, Saitama 351-8510, Japan.
  • Department of Food and Nutritional Sciences, Faculty of Food and Nutritional Sciences, Toyo University, 1-7-11 Akabane-dai, Kita-ku, Tokyo 115-8650, Japan.
  • Department of Nutritional Sciences, Graduate School of Health and Sports Sciences, Toyo University, 1-7-11 Akabane-dai, Kita, Tokyo 115-8650, Japan.

Zitieren

APA

Takahama, Y., Kadoi, A., Tauchi, Y., Kasahara, S., Ishii, K., & Yano, T. (2025). Regulation of Human Colorectal Cancer Cells in Tumor Spheroids by Sodium Butyrate. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00043

Vancouver

Takahama Y, Kadoi A, Tauchi Y, Kasahara S, Ishii K, Yano T. Regulation of Human Colorectal Cancer Cells in Tumor Spheroids by Sodium Butyrate. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00043

BibTeX
@article{Takahama2025,
  author = {Takahama, Yuzuki and Kadoi, An and Tauchi, Yuno and Kasahara, Satsuki and Ishii, Kyota and Yano, Tomohiro},
  title = {Regulation of Human Colorectal Cancer Cells in Tumor Spheroids by Sodium Butyrate},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00043}
}
Kostenlos starten →